Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03522597 · ClinicalTrials.gov registry record
Metabolism, Breastmilk, and Microbiome
A clinical trial of Obesity and Diabetes, Gestational, sponsored by University of Minnesota.
- Completed
- Registry status
- 2,050
- Enrollment target
- 1
- Study location
NCT03522597: Completed study of Obesity and Diabetes, Gestational, sponsored by University of Minnesota.
NCT03522597 is a study of Obesity and Diabetes, Gestational that has completed, run by University of Minnesota. The registered enrollment target is 2,050 participants, above the 817-participant average among 1,053 other Obesity trials with a reported enrollment target (151% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03522597, a study of Obesity and Diabetes, Gestational, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 2,050 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this pilot study is to compare breast milk composition in mothers of three different metabolic states (normal weight, obese, and gestational diabetic) and to determine the extent to which breastmilk components are transmitted to the infant gut and are associated with the anthropometric and body composition changes in their infants during the first 6 months of life. It is hypothesized that 1) different maternal metabolic states will be associated with differences in breastmilk microbial communities and breastmilk biochemical features, 2) differences in these breastmilk biomarkers will be transmitted to infants and 3) breastmilk microbial and metabolic features will be associated with infant growth outcomes.
Primary Outcome
Change in the diversity and abundance of breast milk and infant gut bacterial and fungal species and strains, and functional microbiome profiles
Conditions Studied
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,050 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2025-07-01 |
What the finished NCT03522597 record still lists
NCT03522597 is an observational study that tracks outcomes without assigning an intervention. Its 2,050 participants enrollment target places it among the larger protocols in the corpus, above the 817-participant average among 1,053 other Obesity trials with a reported enrollment target (151% higher).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT03522597 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03522597 about?
NCT03522597 is a clinical study titled "Metabolism, Breastmilk, and Microbiome". The objective of this pilot study is to compare breast milk composition in mothers of three different metabolic states (normal weight, obese, and gestational diabetic) and to determine the extent to which breastmilk components are transmitted to the infant gut and are associated with the anthropomet...
What is the current status of trial NCT03522597?
This trial is currently completed. The enrollment target is 2,050 participants. The study started on 2018-06-01. Estimated completion is 2025-07-01.
What conditions does trial NCT03522597 study?
This clinical trial studies the following conditions: Obesity, Diabetes, Gestational.
Who is sponsoring clinical trial NCT03522597?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03522597 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03522597's enrollment target sits among peer trials
2,050 42nd of 1053 higher than 1,011 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05050084 · 2,050 participants · Phase 3
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
- NCT05688982 · 2,049 participants · NA
MOLAR: Mapping Oral Health and Local Area Resources
- NCT06833476 · 2,044 participants
TTVR STRONG Under Coverage With Evidence Development (CED) Study
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI